These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20770071)

  • 1. A NOTE ON THE TREATMENT OF CUTANEOUS ERYSIPELAS WITH BRILLIANT GREEN.
    Adams JE
    Br Med J; 1920 Nov; 2(3125):779-80. PubMed ID: 20770071
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case of Facial Erysipelas Successfully Treated by Brilliant Green.
    Paul CC
    Ind Med Gaz; 1926 Oct; 61(10):502. PubMed ID: 29011267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disseminated cutaneous leishmaniasis secondary to lymphoedema: two cases].
    Meziou TJ; Chaabène H; Masmoudi A; Boudaya S; Cheikhrouhou H; Bouassida S; Turki H
    Ann Dermatol Venereol; 2008 Feb; 135(2):123-6. PubMed ID: 18342094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ERYSIPELAS AND TANDERIL; CLINICAL NOTE].
    FERNANDEZSANZ S
    Hisp Med; 1964 Jul; 21():413-9. PubMed ID: 14189856
    [No Abstract]   [Full Text] [Related]  

  • 5. Food handler's infection (swine erysipelas) in man.
    DEBENHAM M
    Calif Med; 1949 Jun; 70(6):486-8. PubMed ID: 18131686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between digital camera and spectrophotometer for sensitive and selective kinetic determination of brilliant green in wastewaters.
    Damirchi S; Maliheh AK; Heidari T; Es'haghi Z; Chamsaz M
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jan; 206():232-239. PubMed ID: 30119003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ON THE HISTOPATHOLOGY OF THE CUTANEOUS LYMPH VESSELS IN CHRONIC RECURRENT ERYSIPELAS OF THE LOWER EXTREMITIES].
    TAPPEINER J; PFLEGER L
    Hautarzt; 1964 May; 15():218-23. PubMed ID: 14213267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrent erysipelas].
    Dangoisse C; Ledoux M
    Rev Med Brux; 1991 Sep; 12(7):253-6. PubMed ID: 1925175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic criteria for erysipelas].
    Vaillant L
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):326-33. PubMed ID: 11319359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery.
    Rodrigues EB; Penha FM; de Paula Fiod Costa E; Maia M; Dib E; Moraes M; Meyer CH; Magalhaes O; Melo GB; Stefano V; Dias AB; Farah ME
    Am J Ophthalmol; 2010 Feb; 149(2):265-77. PubMed ID: 19896637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic corticosteroids and their place in the management of hemorrhagic erysipelas].
    Ezzine Sebai N; Hicheri J; Trojjet S; Khaled A; Badri T; Zeglaoui F; Fezaa B; Ridha Kamoun M
    Tunis Med; 2008 Jan; 86(1):49-52. PubMed ID: 19472700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact Hypersensitivity to Brilliant Green and Gentian Violet.
    Pasricha JS; Gupta R
    Indian J Dermatol Venereol Leprol; 1982; 48(3):151-153. PubMed ID: 28193943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferment of slaughtering in swine affected by cutaneous erysipelas.
    Colavita G; Vergara A; Ianieri A
    Meat Sci; 2006 Feb; 72(2):203-5. PubMed ID: 22061544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2 cases of melanomatous erysipelas--differential diagnosis and terminology].
    Lindmaier A; Jurecka W
    Hautarzt; 1990 Nov; 41(11):628-32. PubMed ID: 2276918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erysipelas is not the same as erysipelas and leishmaniasis is not the same as Leishmaniasis].
    Sunderkötter C
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):185-6. PubMed ID: 25721624
    [No Abstract]   [Full Text] [Related]  

  • 16. Erysipelas after breast cancer treatment (26 cases).
    Masmoudi A; Maaloul I; Turki H; Elloumi Y; Marrekchi S; Bouassida S; Ben Jemaa M; Zahaf A
    Dermatol Online J; 2005 Dec; 11(3):12. PubMed ID: 16409908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-erysipelas: A new atypical cutaneous manifestation of parvovirus B19 primary infection.
    Kechaou I; Cherif E; Boukhris I; Azzabi S; Kaouech Z
    Med Mal Infect; 2016 Mar; 46(2):107-8. PubMed ID: 26791960
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of brilliant green on the motility of Salmonellae and other selected microorganisms.
    Sessoms AR; Banwart GJ
    Appl Microbiol; 1969 Oct; 18(4):542-6. PubMed ID: 4983955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in plating efficiency of Salmonellae on eight lots of brilliant green agar.
    Read RB; Reyes AL
    Appl Microbiol; 1968 May; 16(5):746-8. PubMed ID: 4872997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoscintigraphic evaluation in patients after erysipelas.
    de Godoy JM; de Godoy MF; Valente A; Camacho EL; Paiva EV
    Lymphology; 2000 Dec; 33(4):177-80. PubMed ID: 11191659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.